161 related articles for article (PubMed ID: 23562196)
1. A proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study.
Rank MA; Hagan JB; Samant SA; Kita H
Am J Rhinol Allergy; 2013; 27(2):98-101. PubMed ID: 23562196
[TBL] [Abstract][Full Text] [Related]
2. Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations.
Divekar RD; Samant S; Rank MA; Hagan J; Lal D; O'Brien EK; Kita H
Clin Exp Allergy; 2015 Apr; 45(4):767-78. PubMed ID: 25429844
[TBL] [Abstract][Full Text] [Related]
3. Nasal biomarker profiles in acute and chronic rhinosinusitis.
Riechelmann H; Deutschle T; Rozsasi A; Keck T; Polzehl D; Bürner H
Clin Exp Allergy; 2005 Sep; 35(9):1186-91. PubMed ID: 16164446
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil extracellular trap formation is closely associated with disease severity in chronic rhinosinusitis regardless of nasal polyp status.
Hwang CS; Park SC; Cho HJ; Park DJ; Yoon JH; Kim CH
Sci Rep; 2019 May; 9(1):8061. PubMed ID: 31147604
[TBL] [Abstract][Full Text] [Related]
5. Assessing the clinico-immunological profile of patients with obesity and chronic rhinosinusitis.
Chaaban MR; Asosingh K; Comhair S; Hoying D
Int Forum Allergy Rhinol; 2024 Jun; 14(6):1036-1045. PubMed ID: 37997535
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis.
Bradley DT; Kountakis SE
Laryngoscope; 2005 Apr; 115(4):684-6. PubMed ID: 15805881
[TBL] [Abstract][Full Text] [Related]
7. Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review.
Wu D; Bleier B; Wei Y
J Otolaryngol Head Neck Surg; 2020 Aug; 49(1):62. PubMed ID: 32811568
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.
Pace E; Scafidi V; Di Bona D; Siena L; Chiappara G; Ferraro M; La Grutta S; Gallina S; Speciale R; Ballacchino A; Bachert C; Bousquet J; Gjomarkaj M
Allergy; 2012 Jul; 67(7):878-86. PubMed ID: 22583192
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular staging for the severity of chronic rhinosinusitis.
Kountakis SE; Arango P; Bradley D; Wade ZK; Borish L
Laryngoscope; 2004 Nov; 114(11):1895-905. PubMed ID: 15510011
[TBL] [Abstract][Full Text] [Related]
10. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
[TBL] [Abstract][Full Text] [Related]
11. Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss.
Hauser LJ; Chandra RK; Li P; Turner JH
Int Forum Allergy Rhinol; 2017 Oct; 7(10):957-962. PubMed ID: 28742240
[TBL] [Abstract][Full Text] [Related]
12. Chapter 4: Chronic rhinosinusitis.
Settipane RA; Peters AT; Chandra R
Am J Rhinol Allergy; 2013; 27 Suppl 1():S11-5. PubMed ID: 23711032
[TBL] [Abstract][Full Text] [Related]
13. [Cell activation markers in rhinitis and rhinosinusitis. 1: Eosinophilic cationic protein (ECP)].
Klimek L; Rasp G
Laryngorhinootologie; 1996 Nov; 75(11):665-70. PubMed ID: 9063834
[TBL] [Abstract][Full Text] [Related]
14. An immunologic test for chronic rhinosinusitis based on free intranasal eosinophilic major basic protein.
Ponikau JU; Winter LA; Kephart GM; Squillace DL; Hershcovitch MD; Moon S; Sherris DA; Kern EB; Gleich GJ; Kita H
Int Forum Allergy Rhinol; 2015 Jan; 5(1):28-35. PubMed ID: 25266917
[TBL] [Abstract][Full Text] [Related]
15. Increased CXCL10 expression in nasal fibroblasts from patients with refractory chronic rhinosinusitis and asthma.
Yoshikawa M; Wada K; Yoshimura T; Asaka D; Okada N; Matsumoto K; Moriyama H
Allergol Int; 2013 Dec; 62(4):495-502. PubMed ID: 24153332
[TBL] [Abstract][Full Text] [Related]
16. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
17. Investigating the correlation between mucus cytokine levels, inflammatory cell counts, and baseline quality-of-life measures in chronic rhinosinusitis.
Chowdhury NI; Chandra RK; Li P; Ely K; Turner JH
Int Forum Allergy Rhinol; 2019 May; 9(5):538-544. PubMed ID: 30629853
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-9 and interleukin-17C in chronic rhinosinusitis.
Olcott CM; Han JK; Cunningham TD; Franzese CB
Int Forum Allergy Rhinol; 2016 Aug; 6(8):841-7. PubMed ID: 26989880
[TBL] [Abstract][Full Text] [Related]
19. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
[TBL] [Abstract][Full Text] [Related]
20. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps.
Nakayama T; Sugimoto N; Okada N; Tsurumoto T; Mitsuyoshi R; Takaishi S; Asaka D; Kojima H; Yoshikawa M; Tanaka Y; Haruna SI
Auris Nasus Larynx; 2019 Jun; 46(3):374-383. PubMed ID: 30243753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
